Background Image

Latest News

Maxwellia strengthens its Marketing team with two new appointments

6 September 2021

Maxwellia strengthens its Marketing team with two new appointments

Maxwellia, the UK’s only company 100% dedicated to switching Rx to OTC medicines has created two new senior roles in its marketing team.  The team expansion follows the success of the recent landmark reclassification of the progestogen only pill by the MHRA, a change spearheaded by Maxwellia, and the company’s subsequent launch of its first product Lovima® in July.  The new marketing team will be vital in supporting the company’s innovative product pipeline and ensure continued success as the business grows in 2021/22.

Emma Haworth - Women’s Health Senior Brand Manager, holds a first-class honours degree in Biomedical Science and is a CIM certified marketeer. She has worked extensively in pharmaceutical marketing, a career which includes varied senior roles most recently at Thornton & Ross where she worked on the dermatology and bone health portfolios. With a thorough understanding of the OTC market, Emma shares the Maxwellia vision of enabling greater self-care and the revolution of women’s health and will be taking responsibility for building the women’s health portfolio.

Shaunagh Igoe - Lovima Brand Manager, joins Maxwellia from 3M Healthcare where she was involved in building customer success models and developing customer strategy. She brings with her valuable global brand experience and OTC consumer insight. Understanding the patient story and retelling that story to help bring brands to market that improve people’s lives is what really motivates Shaunagh. Her new role will see her build a successful brand platform for Lovima® - a brand that represents the most significant innovation in women’s health for 60 years.

Maxwellia founder and CEO, Anna Maxwell says: “These two new roles will play an important part in managing the complexity of our UK marketing strategy as we move into a new phase for Maxwellia. We now have Lovima® - our first product to market - on shelf and have an innovative pipeline that we are really excited about. We welcome Emma and Shaunagh, both of whom share our vision of widening access to medicines through pharmacy and who understand that real value of empowering people to self-care in the UK.”